Q2 2024 Holdings
Filed 2024-08-14 | 52 holdings | $112.3M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2024-10-03) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| ELI Lilly & Co(LLY) | COM | 532457108 | $8.8M | 9,700 | 7.8% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $5.2M | 32,900 | 4.6% |
| Beigene LTD(ONC)A | SPONSORED ADR | 07725L102 | $4.7M | 33,200 | 4.2% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $4.5M | 251,600 | 4.0% |
| The Cigna Group(CI) | COM | 125523100 | $4.0M | 12,200 | 3.6% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $3.8M | 84,790 | 3.4% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $3.8M | 56,800 | 3.4% |
| Amgen Inc(AMGN) | COM | 031162100 | $3.7M | 11,800 | 3.3% |
| Travere Therapeutics Inc(TVTX)A | COM | 89422G107 | $3.6M | 443,379 | 3.2% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $3.0M | 10,800 | 2.7% |
| Avadel Pharmaceuticals PLC | COM SHS | G29687103 | $2.9M | 209,092 | 2.6% |
| Dexcom Inc(DXCM)A | COM | 252131107 | $2.9M | 25,928 | 2.6% |
| Autolus Therapeutics PLC(AUTL)A | SPON ADS | 05280R100 | $2.9M | 839,472 | 2.6% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $2.8M | 6,358 | 2.5% |
| DR Reddys Labs LTD(RDY)A | ADR | 256135203 | $2.8M | 36,300 | 2.5% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $2.7M | 61,000 | 2.4% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $2.7M | 20,000 | 2.4% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $2.7M | 131,742 | 2.4% |
| Merus N VA | COM | N5749R100 | $2.7M | 45,100 | 2.4% |
| Masimo Corp(MASI) | COM | 574795100 | $2.5M | 19,800 | 2.2% |
| Centessa Pharmaceuticals PLC(CNTA)A | SPONSORED ADS | 152309100 | $2.5M | 274,900 | 2.2% |
| Wave Life Sciences LTD(WVE)A | SHS | Y95308105 | $2.4M | 488,135 | 2.2% |
| Guardant Health Inc(GH) | COM | 40131M109 | $2.3M | 79,000 | 2.0% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $2.2M | 300,200 | 2.0% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $2.2M | 82,400 | 2.0% |
| Natera Inc(NTRA)A | COM | 632307104 | $2.0M | 18,650 | 1.8% |
| Biohaven LTD(BHVN)A | COM | G1110E107 | $2.0M | 57,800 | 1.8% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $2.0M | 78,907 | 1.8% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $1.9M | 302,700 | 1.7% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $1.8M | 46,900 | 1.6% |
| Alphatec Hldgs Inc(ATEC)A | COM NEW | 02081G201 | $1.7M | 162,100 | 1.5% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $1.5M | 514,900 | 1.4% |
| ZAI LAB LTD(ZLAB)A | ADR | 98887Q104 | $1.5M | 86,700 | 1.3% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $1.3M | 124,000 | 1.2% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $1.2M | 282,400 | 1.1% |
| Alvotech(ALVO) | ORDINARY SHARES | L01800108 | $1.2M | 99,000 | 1.1% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $1.0M | 1,127,699 | 0.9% |
| Elevation Oncology IncA | COM | 28623U101 | $997.2K | 369,322 | 0.9% |
| Establishment Labs Hldgs Inc(ESTA)A | COM | G31249108 | $986.0K | 21,700 | 0.9% |
| Syros Pharmaceuticals Inc(SYRS)A | COM NEW | 87184Q206 | $821.3K | 159,175 | 0.7% |
| Quanterix Corp(QTRX)A | COM | 74766Q101 | $788.0K | 59,650 | 0.7% |
| Q32 BIO Inc(QTTB)A | COM | 746964105 | $787.4K | 43,865 | 0.7% |
| Vyne Therapeutics Inc(VYNE)A | COM | 92941V308 | $696.3K | 353,434 | 0.6% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $580.6K | 358,400 | 0.5% |
| Aprea Therapeutics Inc(APRE) | COM NEW | 03836J201 | $558.3K | 137,174 | 0.5% |
| Tectonic Therapeutic Inc(TECX)A | COM | 878972108 | $533.4K | 32,389 | 0.5% |
| Adagene Inc(ADAG)A | ADS | 005329107 | $461.8K | 150,876 | 0.4% |
| I MAB(NBP) | SPONSORED ADS | 44975P103 | $453.2K | 271,400 | 0.4% |
| Procaps Group SA(PROCF)A | SHS | L7756P102 | $321.1K | 126,901 | 0.3% |
| Hillevax Inc | COM | 43157M102 | $260.3K | 18,000 | 0.2% |